Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors.
Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, Caldarella C, Rigante M, Gessi M, Lauretti L, De Marinis L, Olivi A, Pontecorvi A, Doglietto F. Bianchi A, et al. Among authors: de marinis l. Front Endocrinol (Lausanne). 2023 May 3;14:1123267. doi: 10.3389/fendo.2023.1123267. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37206441 Free PMC article. Review.
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.
Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F, Angelini F, Lauriola L, Vellone V, Doglietto F, Ambrosio MR, Maira G, Giustina A, degli Uberti EC, Pontecorvi A, De Marinis L. Fusco A, et al. Among authors: de marinis l. J Clin Endocrinol Metab. 2008 Jul;93(7):2746-50. doi: 10.1210/jc.2008-0126. Epub 2008 May 6. J Clin Endocrinol Metab. 2008. PMID: 18460561
Isolated growth hormone deficiency: clinical entity?
Bianchi A, Giampietro A, Pontecorvi A, De Marinis L. Bianchi A, et al. Among authors: de marinis l. J Endocrinol Invest. 2008 Sep;31(9 Suppl):12-5. J Endocrinol Invest. 2008. PMID: 19020379 Review.
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.
Bianchi A, Valentini F, Iuorio R, Poggi M, Baldelli R, Passeri M, Giampietro A, Tartaglione L, Chiloiro S, Appetecchia M, Gargiulo P, Fabbri A, Toscano V, Pontecorvi A, De Marinis L. Bianchi A, et al. Among authors: de marinis l. J Exp Clin Cancer Res. 2013 Jun 21;32(1):40. doi: 10.1186/1756-9966-32-40. J Exp Clin Cancer Res. 2013. PMID: 23799893 Free PMC article.
The Changing Clinical Spectrum of Hypophysitis.
Chiloiro S, Capoluongo ED, Tartaglione T, Giampietro A, Bianchi A, Giustina A, Pontecorvi A, De Marinis L. Chiloiro S, et al. Among authors: de marinis l. Trends Endocrinol Metab. 2019 Sep;30(9):590-602. doi: 10.1016/j.tem.2019.06.004. Epub 2019 Jul 22. Trends Endocrinol Metab. 2019. PMID: 31345630 Review.
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response.
Chiloiro S, Giampietro A, Mirra F, Donfrancesco F, Tartaglione T, Mattogno PP, Angelini F, Liverana L, Gessi M, Carmelo A, Rindi G, Giustina A, Fleseriu M, Pontecorvi A, De Marinis L, Bianchi A. Chiloiro S, et al. Among authors: de marinis l. Eur J Endocrinol. 2021 Feb;184(2):217-229. doi: 10.1530/EJE-20-0767. Eur J Endocrinol. 2021. PMID: 33136550
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study.
Bima C, Chiloiro S, Giampietro A, Gessi M, Mattogno PP, Lauretti L, Anile C, Rindi G, Pontecorvi A, De Marinis L, Bianchi A. Bima C, et al. Among authors: de marinis l. Front Endocrinol (Lausanne). 2021 Jul 12;12:684055. doi: 10.3389/fendo.2021.684055. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34322092 Free PMC article.
284 results